Duc Doan

Duc Doan is a seasoned scientist specializing in targeted therapeutics with extensive experience in drug development and biochemical research. Presently serving as Scientist III at MacroGenics, Inc., Duc has previously held significant roles at NextCure, Inc. and Eisai US, where responsibilities included co-leading antibody-drug conjugate programs and establishing a new omics platform for researching innate immune receptors. With a strong academic background, including a PhD in Biochemical Pharmacology and a Master's in Medicinal and Pharmaceutical Chemistry from Université du Québec, Duc has contributed to various projects across prominent institutions, focusing on protein folding, neuroprotective agents, and organic synthesis.